Herman Steen Email and Phone Number
Herman Steen work email
- Valid
- Valid
Herman Steen personal email
Herman Steen is a Bio-pharma entrepreneur, Cortalix BV, Omnicin Therapeutics BV at Cortalix BV. He possess expertise in drug development, clinical development, cro, clinical research, pharmaceutics and 16 more skills. He is proficient in Engels.
-
Founder And C.E.O.Cortalix Bv Mar 2023 - PresentCortalix is a clinical-stage radiopharmaceutical company developing molecular PET imaging diagnostics and targeted radiotherapeutics based on its proprietary discovery platform of synthetic single-domain antibody libraries (nanobodies).
-
C.E.O. Biorion Technologies BvCortalix Bv Jun 2007 - Mar 2023BiOrion is a clinical-stage Dutch biopharmaceutical company engaged in the development of PET imaging diagnostics for fibrotic diseases, including fibrotic cancers, such as colon cancer. After an unexpected bankruptcy early 2023, assets and know-how were purchased by Cortalix BV.
-
Co-Founder And C.B.O.Omnicin Therapeutics Bv Dec 2019 - PresentOmnicin is a biopharmaceutical company involved in the development of supportive therapies for existing antibiotics, which make multi-resistant bacteria sensitive again. We are developing Bismocin (TM), a dry powder inhalation drug based on bismuth subcitrate, which is administered to patients with a life-threatening chronic lung infection for whom no further treatment options are available. -
Pharma Consultancy & Interim ManagementSasso Pharma Consultancy Jan 2009 - PresentSasso Pharma Consultancy provides interim management and consultancy assignments based on 30 years of experience in the pharmaceutical industry. From start-up to scale-up, but always 'boots on the ground'. -
Founder And C.E.O.Chaperone Pharma Bv Jan 2017 - PresentChaperone Pharma is a biopharmaceutical holding company, engaged in funding business initiatives for biopharmaceutical products and services mainly based on a single domain antibodies platform. -
Co-Founder And C.E.O. Nyken Therapeutics BvChaperone Pharma Bv May 2009 - Dec 2016Nyken is a biopharmaceutical company engaged in the development of heat shock factor 1 (HSF1) activating drugs to treat proteostasis-related diseases such as atrial fibrillation, acute kidney injury and a selection of CNS pathologies. In 2016, Nyken’s intellectual property and patent portfolio on HSF1 activating drugs has been acquired by Chaperone Pharma, a Dutch biopharmaceutical company.
-
Member Board Of DirectorsPsr Orphan Experts (Now Ergomed) Jun 2010 - Sep 2017Hoofddorp, Nl -
Co-Founder, Owner And Director Corporate StrategyPsr Orphan Experts (Now Ergomed) Jun 2005 - May 2010Hoofddorp, NlPSR Group is the leading expert in orphan drug development. It is a medium-sized, international Clinical Contract Research Organisation (CRO) headquartered in the Netherlands. The company assists their clients to design and execute successful clinical development strategies for orphan indications. They are specialized in complex clinical development programs requiring innovative regulatory and clinical approaches. Since September 2017, PSR Group is wholly owned by London UK based Ergomed, allowing PSR Group to cover services in the world's major pharmaceutical markets.
-
Co-Founder And C.E.O. Pharmascope BvIqvia Belux May 1998 - May 2005Zaventem, Flemish Brabant, BePharmaScope is a European clinical contract research and pharma recruitment organization. In 2005 the Dutch affiliate of PharmaScope was acquired by Quintiles Transnational Corp. (currently IQVIA), whereas the international operating affiliates of PharmaScope International were acquired and merged to PSR Group. -
Clinical Research Manager, Byk Nederland (Altana Pharma)Takeda Nederland Apr 1996 - Apr 1998Hoofddorp, NlGastro-intestinal (Pantozol, pantoprazole) and Pulmonological (Daxas, roflumilast) studies. -
Clinical Research Associate, Byk Nederland (Altana PharmaTakeda Nederland Mar 1994 - Mar 1996Hoofddorp, NlGastro-intestinal (Pantozol, pantoprazole) and pulmonological (Daxas, roflumilast) studies.
-
PostdocSanquin Jul 1992 - Feb 1994Amsterdam, Noord-Holland, NlResearch Fellow on Factor VIII / Von Willebrand Factor interactions.
Herman Steen Skills
Herman Steen Education Details
-
University Of GroningenPharmacology -
Koninklijke MarineOfficier Koninklijke Marine Reserve
-
University Of GroningenMedical Biology
-
Christelijk Lyceum AlmeloVwo
Frequently Asked Questions about Herman Steen
What company does Herman Steen work for?
Herman Steen works for Cortalix Bv
What is Herman Steen's role at the current company?
Herman Steen's current role is Bio-pharma entrepreneur, Cortalix BV, Omnicin Therapeutics BV.
What is Herman Steen's email address?
Herman Steen's email address is he****@****ion.com
What schools did Herman Steen attend?
Herman Steen attended University Of Groningen, Koninklijke Marine, University Of Groningen, Christelijk Lyceum Almelo.
What are some of Herman Steen's interests?
Herman Steen has interest in Pharma Business Start Up Services, Clinical Research, Business Consultancy.
What skills is Herman Steen known for?
Herman Steen has skills like Drug Development, Clinical Development, Cro, Clinical Research, Pharmaceutics, Pharmaceutical Industry, Biopharmaceuticals, Lifesciences, Clinical Trials, Biotechnology, Oncology, Cell.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial